MethylPurify: tumor purity deconvolution and differential methylation detection from single tumor DNA methylomes

We propose a statistical algorithm MethylPurify that uses regions with bisulfite reads showing discordant methylation levels to infer tumor purity from tumor samples alone. MethylPurify can identify differentially methylated regions (DMRs) from individual tumor methylome samples, without genomic variation information or prior knowledge from other datasets. In simulations with mixed bisulfite reads from cancer and normal cell lines, MethylPurify correctly inferred tumor purity and identified over 96% of the DMRs. From patient data, MethylPurify gave satisfactory DMR calls from tumor methylome samples alone, and revealed potential missed DMRs by tumor to normal comparison due to tumor heterogeneity.

[1]  Lee E. Edsall,et al.  Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.

[2]  K D Robertson,et al.  DNA methylation: past, present and future directions. , 2000, Carcinogenesis.

[3]  Stephan Beck,et al.  The methylome: approaches for global DNA methylation profiling. , 2008, Trends in genetics : TIG.

[4]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[5]  P. Laird,et al.  Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina–associated domains , 2011, Nature Genetics.

[6]  Li Zhang,et al.  PurityEst: estimating purity of human tumor samples using next-generation sequencing data , 2012, Bioinform..

[7]  R. Jaenisch,et al.  Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.

[8]  Jianfeng Xu,et al.  BACOM: in silico detection of genomic deletion types and correction of normal cell contamination in copy number data , 2011, Bioinform..

[9]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[10]  P. Laird,et al.  Bis-SNP: Combined DNA methylation and SNP calling for Bisulfite-seq data , 2012, Genome Biology.

[11]  R. Ward,et al.  The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. , 2003, The American journal of pathology.

[12]  M. Esteller.  Aberrant DNA methylation as a cancer-inducing mechanism. , 2005, Annual review of pharmacology and toxicology.

[13]  Zachary D. Smith,et al.  Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution , 2010, Nature Methods.

[14]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[15]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[16]  Wei Li,et al.  BSMAP: whole genome bisulfite sequence MAPping program , 2009, BMC Bioinformatics.

[17]  Michael Q. Zhang,et al.  Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications , 2010, Nature Biotechnology.

[18]  Chun Xing Li,et al.  Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 , 2000, Nature Genetics.

[19]  J. Issa.  DNA methylation as a therapeutic target in cancer. , 2008, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  Keith L. Ligon,et al.  DNA hypomethylation within specific transposable element families associates with tissue-specific enhancer landscape , 2013, Nature Genetics.

[21]  G. McLachlan,et al.  The EM Algorithm and Extensions: Second Edition , 2008 .

[22]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[23]  J. Minna,et al.  Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. , 2001, Journal of the National Cancer Institute.

[24]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[25]  A. McKenna,et al.  Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.

[26]  A. Feinberg,et al.  DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. , 2002, Seminars in cancer biology.

[27]  Terence P. Speed,et al.  TumorBoost: Normalization of allele-specific tumor copy numbers from a single pair of tumor-normal genotyping microarrays , 2010, BMC Bioinformatics.

[28]  G. McLachlan,et al.  The EM algorithm and extensions , 1996 .

[29]  Michael Q. Zhang,et al.  High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing , 2009 .

[30]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[31]  Simon Kasif,et al.  Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells , 2014, Cell.

[32]  Kathleen R. Cho,et al.  Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. , 2008, Cancer research.

[33]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[34]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[35]  A. Feinberg,et al.  Comprehensive High‐Throughput Arrays for Relative Methylation (CHARM) , 2010, Current protocols in human genetics.

[36]  K. Robertson.  DNA methylation and human disease , 2005, Nature Reviews Genetics.

[37]  A. Feinberg,et al.  Increased methylation variation in epigenetic domains across cancer types , 2011, Nature Genetics.

[38]  B. Ren,et al.  Base-Resolution Analyses of Sequence and Parent-of-Origin Dependent DNA Methylation in the Mouse Genome , 2012, Cell.

[39]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[40]  P. Ainsworth,et al.  Allele-specific non-CpG methylation of the Nf1 gene during early mouse development. , 2001, Developmental biology.

[41]  R. Jaenisch,et al.  RNA and the Epigenetic Regulation of X Chromosome Inactivation , 1998, Cell.

[42]  Rachel Jones,et al.  Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Genetics.

[43]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[44]  C. Perou,et al.  Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.

[45]  Zachary D. Smith,et al.  Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling , 2011, Nature Protocols.

[46]  Brian J. Stevenson,et al.  Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. , 2012, Genome research.

[47]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[48]  Gary L Rosner,et al.  Tumour vasculature: On the verge of collapse , 2005, Nature Reviews Cancer.

[49]  H. Kitchener,et al.  Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation , 2012, Genome Medicine.

[50]  Quaid Morris,et al.  Computational purification of individual tumor gene expression profiles leads to significant improvements in prognostic prediction , 2013, Genome Medicine.

[51]  Matthew D Dean,et al.  Genomic landscape of human allele-specific DNA methylation , 2012, Proceedings of the National Academy of Sciences.

[52]  Rudolf Jaenisch,et al.  Role for DNA methylation in genomic imprinting , 1993, Nature.

[53]  Fatima Al-Shahrour,et al.  Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. , 2010, Genome research.

[54]  A. Gnirke,et al.  Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis , 2005, Nucleic acids research.

[55]  Andrew E. Teschendorff,et al.  Differential variability improves the identification of cancer risk markers in DNA methylation studies profiling precursor cancer lesions , 2012, Bioinform..

[56]  S. Morrison,et al.  Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.

[57]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.